A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis
Clinical trial NCT06119529 · TERMINATED
Trial details
- NCT number
- NCT06119529
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-04-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.